FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:861-867 March 30, 1995 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Colorectal cancer ranks second as a cause of death due to cancer in the United States; approximately 56,000 deaths and 150,000 new cases are predicted this year.¹ Improvements in fiberoptic technology over the past two decades have made the elimination of colorectal cancer as a major cause of death a theoretical possibility. Since colonoscopic screening of the entire population is not practical, this procedure must be targeted to those known to be at higher than average risk, as indicated by measurable characteristics. In this article we shall discuss the assessment of risk for colorectal cancer, particularly as it relates to . . . [Full Text of this Article]

Biologic Mechanisms

Confirming the Adenoma–Carcinoma Sequence

Mechanisms of Carcinogenesis

Molecular Genetics

Screening and Surveillance

Family History

Fecal Occult-Blood Testing

Flexible Sigmoidoscopy

Other Techniques for the Detection of Neoplasms

            Barium Enema

            Hydrocolonic Sonography

            Colonoscopy

Cost Effectiveness

Summary

Source Information

From the Gastroenterology Section, Medical Service, Department of Veterans Affairs Medical Center, and the Division of Gastroenterology, Department of Medicine, University of California, San Francisco — both in San Francisco.

Address reprint requests to Dr. Toribara at the G.I. Research Laboratory (151M2), Department of Veterans Affairs Medical Center, 4150 Clement St., San Francisco, CA 94121.

References

Related Letters:

Screening for Colorectal Cancer
Dubois G., The French Working Group on Colorectal Cancer Screening , Redelmeier D. A., Toribara N. W., Sleisenger M. H.
Extract | Full Text  
N Engl J Med 1995; 333:460-461, Aug 17, 1995. Correspondence

This article has been cited by other articles:

• Kong, S L, Salto-Tellez, M, Leong, A P K, Chan, Y H, Koay, E S C (2005). Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications. J. Clin. Pathol. 58: 839-844 [Abstract] [Full Text]  
• Geenen, R. W. F., Hussain, S. M., Cademartiri, F., Poley, J.-W., Siersema, P. D., Krestin, G. P. (2004). CT and MR Colonography: Scanning Techniques, Postprocessing, and Emphasis on Polyp Detection. RadioGraphics 24: e18-e18 [Abstract] [Full Text]  
• Lenander, C, Roblick, U J, Habermann, J K, Ost, A, Tryggvason, K, Auer, G (2003). Laminin 5 {gamma}2 chain expression: a marker of early invasiveness in colorectal adenomas. Mol. Pathol. 56: 342-346 [Abstract] [Full Text]  
• Iannaccone, R., Laghi, A., Catalano, C., Brink, J. A., Mangiapane, F., Trenna, S., Piacentini, F., Passariello, R. (2003). Detection of Colorectal Lesions: Lower-Dose Multi-Detector Row Helical CT Colonography Compared with Conventional Colonoscopy. Radiology 229: 775-781 [Abstract] [Full Text]  
• Gilchrist, D. M. (2002). Medical genetics: 3. An approach to the adult with a genetic disorder. CMAJ 167: 1021-1029 [Abstract] [Full Text]  
• Smith, G., Carey, F. A., Beattie, J., Wilkie, M. J. V., Lightfoot, T. J., Coxhead, J., Garner, R. C., Steele, R. J. C., Wolf, C. R. (2002). Mutations in APC, Kirsten-ras, and p53---alternative genetic pathways to colorectal cancer. Proc. Natl. Acad. Sci. USA 99: 9433-9438 [Abstract] [Full Text]  
• Autier, P. (2002). Should organised faecal occult blood test screening be established?. Ann Oncol 13: 57-60 [Full Text]  
• Barry, M. J. (2002). Fecal occult blood testing for colorectal cancer: a perspective. Ann Oncol 13: 61-64 [Abstract] [Full Text]  
• Ladabaum, U., Chopra, C. L., Huang, G., Scheiman, J. M., Chernew, M. E., Fendrick, A. M. (2001). Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis. ANN INTERN MED 135: 769-781 [Abstract] [Full Text]  
• Fava, T. A., Desnoyers, R., Schulz, S., Park, J., Weinberg, D., Mitchell, E., Waldman, S. A. (2001). Ectopic Expression of Guanylyl Cyclase C in CD34+ Progenitor Cells in Peripheral Blood. JCO 19: 3951-3959 [Abstract] [Full Text]  
• Luboldt, W., Luz, O., Vonthein, R., Heuschmid, M., Seemann, M., Schaefer, J., Stueker, D., Claussen, C. D. (2001). Three-Dimensional Double-Contrast MR Colonography: A Display Method Simulating Double-Contrast Barium Enema. Am. J. Roentgenol. 176: 930-932 [Full Text]  
• Shen, C.-Y., Yu, J.-C., Lo, Y.-L., Kuo, C.-H., Yue, C.-T., Jou, Y.-S., Huang, C.-S., Lung, J.-C., Wu, C.-W. (2000). Genome-wide Search for Loss of Heterozygosity Using Laser Capture Microdissected Tissue of Breast Carcinoma: An Implication for Mutator Phenotype and Breast Cancer Pathogenesis. Cancer Res. 60: 3884-3892 [Abstract] [Full Text]  
• Holtzman, N. A, Shapiro, D. (1998). The new genetics: Genetic testing and public policy. BMJ 316: 852-856 [Full Text]  
• Holtzman, N. A., Murphy, P. D., Watson, M. S., Barr, P. A. (1997). Predictive Genetic Testing: From Basic Research to Clinical Practice. Science 278: 602-605 [Abstract] [Full Text]  
• Levin, B., Hess, K., Johnson, C. (1997). Screening for Colorectal Cancer: A Comparison of 3 Fecal Occult Blood Tests. Arch Intern Med 157: 970-976 [Abstract]  
• Dubois, G., The French Working Group on Colorectal Cancer Scre, , Redelmeier, D. A., Toribara, N. W., Sleisenger, M. H. (1995). Screening for Colorectal Cancer. NEJM 333: 460-461 [Full Text]